The JUPITER study has been the subject of countless headlines reporting the unprecedented reduction in heart attacks with the cholesterol drug, Crestor®. The study has received gushing pronouncements of the inestimable value of statins by my cardiology colleagues.
Pharmaceutical giant, AstraZeneca, sponsored this study of nearly 18,000 people (men 50 years and over, women 60 years and over). Participants took 20 mg per day Crestor or placebo for two years.
The premise being explored was...
This is a 1-year study to evaluate the effects of Crestor and Lipitor on urinary protein excretion in patients with Type 1 or Type 2 diabetes who... Read more »
Two new studies have demonstrated the cholesterol-lowering drug Crestor's effectiveness in fighting heart disease. In the first study, Crestor's... Read more »
This is a study to evaluate the effects of Crestor and Lipitor on urinary protein excretion in people who have protein in their urine but do not have... Read more »
This is a study to evaluate the effects of Crestor and Lipitor on renal function in non-diabetic patients who have protein in their urine and high... Read more »
An ongoing clinical trial funded by Crestor maker AstraZeneca has found that Crestor may be more effective than either Lipitor or Zocor in reducing... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
